X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (77) 77
Publication (21) 21
Book Chapter (5) 5
Book / eBook (4) 4
Book Review (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
index medicus (40) 40
neurofibromatosis (28) 28
child (22) 22
clinical neurology (21) 21
male (21) 21
adult (20) 20
female (20) 20
genetics & heredity (19) 19
neurofibromatosis 1 - complications (18) 18
tumors (18) 18
adolescent (17) 17
middle aged (17) 17
mutation (12) 12
neurofibromatosis 1 - diagnosis (12) 12
neurology (12) 12
neurosciences (12) 12
oncology (12) 12
neurofibromatosis 1 - pathology (11) 11
neurofibromatosis 1 - therapy (11) 11
neurofibromatosis 2 - genetics (11) 11
aged (10) 10
child, preschool (10) 10
children (10) 10
magnetic resonance imaging (10) 10
neurofibromatosis 1 - genetics (10) 10
neurofibromatosis type 2 (10) 10
nf1 (10) 10
schwannomatosis (9) 9
surgery (9) 9
bevacizumab (8) 8
genetic aspects (8) 8
medicine & public health (8) 8
neurofibroma (8) 8
neurofibromatosis 1 (8) 8
vestibular schwannoma (8) 8
animals (7) 7
article (7) 7
diagnosis (7) 7
gene (7) 7
infant (7) 7
nervous system (7) 7
neurofibromatosis 1 - physiopathology (7) 7
neurofibromatosis 2 (7) 7
neurofibromatosis 2 - diagnosis (7) 7
neurofibromatosis 2 - therapy (7) 7
neurofibromatosis type 1 (7) 7
nf2 (7) 7
research (7) 7
risk factors (7) 7
schwannoma (7) 7
young adult (7) 7
cancer (6) 6
glioma (6) 6
malignant peripheral nerve sheath tumor (6) 6
nerve sheath tumors (6) 6
neurofibromin 2 (6) 6
pediatrics (6) 6
plexiform neurofibromas (6) 6
recklinghausen's disease (6) 6
type-1 (6) 6
vestibular schwannomas (6) 6
cohort studies (5) 5
disease models, animal (5) 5
follow-up studies (5) 5
meningioma (5) 5
nerve sheath neoplasms - genetics (5) 5
nerve sheath neoplasms - pathology (5) 5
neurilemmoma - therapy (5) 5
neurofibromatoses - genetics (5) 5
neurofibromatoses - therapy (5) 5
neurofibromatosis 2 - complications (5) 5
neurofibromatosis type-1 (5) 5
neurofibromin (5) 5
optic nerve glioma - complications (5) 5
otorhinolaryngologic diseases (5) 5
phenotype (5) 5
plexiform neurofibroma (5) 5
prognosis (5) 5
treatment outcome (5) 5
abridged index medicus (4) 4
abstracts (4) 4
benign (4) 4
brain tumors (4) 4
clinical trials as topic (4) 4
complications and side effects (4) 4
congenital, hereditary, and neonatal diseases and abnormalities (4) 4
consensus (4) 4
diagnosis, differential (4) 4
ependymoma (4) 4
expression (4) 4
genetic association studies (4) 4
genetic predisposition to disease (4) 4
humanities (4) 4
malignant peripheral nerve sheath tumour (4) 4
medicine (4) 4
mutations (4) 4
natural-history (4) 4
nerve sheath neoplasms - therapy (4) 4
neurilemmoma - genetics (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 03/2002, Volume 62, Issue 5, pp. 1573 - 1577
Neurofibromatosis 1 (NF1) is an autosomal dominant tumor predisposition syndrome in which affected individuals have a greatly increased risk of developing... 
Humans | Middle Aged | Nerve Sheath Neoplasms - etiology | Nerve Sheath Neoplasms - pathology | Adolescent | Neurofibromatosis 1 - complications | Adult | Fluorodeoxyglucose F18 | Nerve Sheath Neoplasms - therapy | Child
Journal Article
American Journal of Medical Genetics Part A, ISSN 1552-4825, 05/2018, Volume 176, Issue 5, pp. 1258 - 1269
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 08/2017, Volume 109, Issue 8, p. djx124
Malignant peripheral nerve sheath tumor (MPNST) is an aggressive soft tissue sarcoma for which the only effective therapy is surgery. In 2016, an international... 
Neurofibromatosis | Risk factors | Research
Journal Article
SAGE Open Medicine, ISSN 2050-3121, 7/2018, Volume 6, p. 2050312118786860
Objectives: To determine intra-rater and inter-rater reliability of functional outcome measures in adults with neurofibromatosis 1 and to ascertain how closely... 
Questionnaires
Journal Article
Handbook of Clinical Neurology, ISSN 0072-9752, 2013, Volume 115, pp. 939 - 955
Neurofibromatosis 1 (NF1) is an inherited neurocutaneous disease that has a major impact on the nervous system, eye, skin, and bone. Individuals with NF1 have... 
Neurofibromatosis 1 | Optic pathway glioma | Neurofibromin | Ras | Malignant peripheral nerve sheath tumor | Neurofibroma | Animals | Humans | Neurofibromatosis 1 - diagnosis | Mice | Neurofibromatosis 1 - genetics | Neurofibromin 1 - genetics | Neurofibromatosis 1 - therapy | Disease Models, Animal
Journal Article
Journal of Neuro-Ophthalmology, ISSN 1070-8022, 09/2017, Volume 37, pp. S23 - S32
Journal Article
EJNMMI research, ISSN 2191-219X, 12/2017, Volume 7, Issue 1, p. 35
Texture features are being increasingly evaluated in F-fluorodeoxyglucose positron emission tomography ( F-FDG PET) as adjunctive imaging biomarkers in a... 
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 02/2007, Volume 44, Issue 2, pp. 81 - 88
Journal Article
Current Opinion in Pediatrics, ISSN 1040-8703, 02/2015, Volume 27, Issue 1, pp. 26 - 33
Purpose of review Over the past decade, substantial insight into the biological function of the tumor suppressors neurofibromin (NF1) and Merlin (NF2) has been... 
meningioma | mitogen-activated protein kinase | mammalian target of rapamycin | malignant peripheral nerve sheath tumor | epidermal growth factor receptor | neurofibromatosis type 1 | neurofibromatosis type 2 | schwannoma | optic pathway glioma | plexiform neurofibroma | YOUNG-ADULTS | PROGRESSIVE PLEXIFORM NEUROFIBROMAS | C-KIT | TYPE-1 NF1 | PHASE-II TRIAL | NF1 INACTIVATION | CLINICAL-TRIALS | PEDIATRICS | VESTIBULAR SCHWANNOMAS | NERVE SHEATH TUMORS | IMATINIB MESYLATE | Neurofibromin 2 - genetics | Humans | Gene Expression Regulation, Neoplastic | Child, Preschool | Infant | Antineoplastic Agents - therapeutic use | Peripheral Nervous System Neoplasms - therapy | Neurofibromatosis 1 - therapy | Molecular Targeted Therapy - trends | Nerve Sheath Neoplasms - pathology | Neurofibromatosis 1 - genetics | Neurofibromin 1 - metabolism | Peripheral Nervous System Neoplasms - pathology | Child | Skin Neoplasms - pathology | Genetic Predisposition to Disease | Nerve Sheath Neoplasms - genetics | Skin Neoplasms - therapy | Clinical Trials as Topic | Neurofibromatosis 2 - genetics | Neurofibromatosis 2 - therapy | Neurofibromatosis 2 - pathology | Magnetic Resonance Imaging | Neurofibromatosis 1 - pathology | Skin Neoplasms - genetics | Nerve Sheath Neoplasms - therapy | Neurofibromin 1 - genetics | Peripheral Nervous System Neoplasms - genetics | ependymoma | epidermal growth factor receptor (EGFR) | mammalian target of rapamycin (mTOR) | mitogen activated protein kinase (MEK)
Journal Article
EJNMMI Research, 12/2017, Volume 7, Issue 1, pp. 1 - 9
Texture features are being increasingly evaluated in super(18)F-fluorodeoxyglucose positron emission tomography ( super(18)F-FDG PET) as adjunctive imaging... 
Journal Article
EJNMMI Research, 04/2017, Volume 7, Issue 1, p. 1
Texture features are being increasingly evaluated in 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) as adjunctive imaging biomarkers in a... 
Studies | Image segmentation | Computed tomography | Emission analysis | Positron emission | Biomarkers | Tomography | Fractals | Texture | Tumors
Journal Article
Journal Article
European Journal of Human Genetics, ISSN 1018-4813, 02/2007, Volume 15, Issue 2, pp. 131 - 138
Neurofibromatosis 1 predisposes affected individuals to the development of benign and malignant tumours that are frequently disfiguring and difficult to... 
Journal Article
Journal Article